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ABSTRACT
Alterations in Progesterone Catabolic Enzymes by Insulin
Caleb Owens Lemley
The current experiments were conducted to determine if insulin could alter the
progesterone catabolic enzymes, cytochrome P450 2C and 3A in vitro, utilizing a mouse
hepatocyte cell-line, or in vivo, utilizing the ovariectomized ewe as a model. The
objectives of the in vitro work were to determine if a four hour challenge with insulin,
glucagon or a combination of both insulin and glucagon would lead to a reduction in the
relative abundance of CYP2C39 or CYP3A13 mRNA, as well as a decrease in the
enzymatic activities of CYP3A and CYP2C subfamilies. A dose dependent decrease (P <
0.05) in CYP2C and CYP3A activity was observed in hepatocytes challenged with
increasing concentrations of insulin, while a challenge with glucagon had no effect on
cytochrome P450 2C or 3A activity. Cytochrome P450 2C activity was decreased (P <
0.05) during exposure of cells to 1.0 nM insulin and 0.1 nM glucagon as well as 0.1 nM
insulin and 1.0 nM glucagon. Cells cultured with 1.0 nM insulin and 0.1 nM glucagon
showed a trend (P < 0.10) for a decrease in CYP3A activity. The relative abundance of
CYP2C39 and CYP3A13 mRNA showed no response to insulin, glucagon or a
combination of insulin and glucagon exposure. These data support a model in which the
known insulin-induced decrease in progesterone catabolism is a result of a reduction in
CYP2C and CYP3A activity. The objectives of the in vivo experiment, utilizing
ovariectomized ewes, were to determine if supplementing feed with either sodium acetate
or sodium propionate altered insulin secretion, hepatic activity of cytochrome P450 2C
and 3A, and/or progesterone clearance. Sixteen ovariectomized ewes were fed 3 kg/d for
10 d, a diet consisting of 50% corn silage, 38% triticale haylage, 12% soy bean meal, and
200 mL of 3.5 M sodium acetate (energy control n = 8) or 2.0 M sodium propionate
(gluconeogenic substrate; n = 8). Insulin concentrations were determined directly before
feeding and at 15, 30, 60, 90, 120, 180, 240, and 300 min. Progesterone clearance from
peripheral circulation was measured by giving a 5 mg injection of progesterone into the
left jugular vein and collecting blood via the right jugular vein at 2, 4, 6, 8, 10, 15, 20 and
30 min afterwards. Liver biopsies were taken one hour after feeding and used for
determination of cytochrome P450 2C and 3A activities. Insulin concentrations in ewes
supplemented with sodium propionate were elevated (P < 0.05) at 15, 30 and 60 minutes
after feeding compared to the sodium acetate group. Cytochrome P450 2C and 3A
activity were decreased (P ≤ 0.05) 1 h after feeding in the sodium propionate treatment
relative to sodium acetate treatment. Clearance of progesterone from the peripheral
circulation, one hour after feeding, was similar between treatment groups, as well as the
average fractional rate constant of progesterone clearance (k). Elucidating a mechanism
to decrease progesterone catabolism, thereby increasing concentrations of progesterone,
seems a logical approach to ameliorate high rates of embryonic loss without
compromising dry matter intake.
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STATEMENT OF THE PROBLEM
Dairy cow pregnancy rates have declined 30% in the last 50 years, and
approximately 80% of the total loss of pregnancy occurs during the embryonic stage,
before day 42 (Inskeep and Dailey, 2005). Throughout the United States, which has
approximately 9 million dairy cows, the industry is losing almost a billion dollars each
year due to low fertility. Starbuck et al. (2004) showed increased pregnancy retention to
week 7 of gestation in dairy cows that were classified, during week 5 of gestation, as high
progesterone (96%) compared to low progesterone (80%). Several authors have shown
that removal of the progesterone source results in abortion of the fetus, which could be
prevented by daily progesterone injections (McDonald et al., 1952; Csapo, 1956).
Plasma progesterone concentrations may be reduced due to a decrease in production
and/or an increase in hepatic catabolism. The two major enzymes involved in
progesterone catabolism belong to the cytochrome P450 2C and 3A subfamilies and the
major metabolites are 21-hydroxyprogesterone and 6β-hydroxyprogesterone, respectively
(Murray, 1991 and 1992).
Both progesterone production and/or hepatic catabolism of progesterone impact
peripheral concentrations of progesterone as well as uterine and embryonic exposure to
progesterone. Therefore, a drop in progesterone concentrations, due to low production or
the normal high rate of catabolism, would result in high embryonic mortality. Miller et
al. (1963) reported a short half-life of 33.8 minutes for progesterone, and Bedford et al.
(1972, 1974) reported a metabolic clearance rate (volume of blood cleared per unit time)
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of progesterone to be approximately 3.5 to 4.3 L/min. Parr et al. (1993) estimated that
90% of progesterone entering the gut and liver is metabolized by these tissues.
Dean and Stock (1975) suggested an internal control mechanism, during
pregnancy, which decreased total hepatic cytochrome P450 activity resulting in elevated
concentrations of progesterone. Decreasing catabolism of progesterone by decreasing
enzymatic activity could increase the concentration of progesterone without the need for
progesterone replacement. Smith et al. (2006) observed a dose-dependent decrease in the
fractional rate constant of progesterone decay in a murine hepatocyte cell line cultured in
the presence of insulin. Hepatocytes treated with physiological concentrations of insulin
and glucagon, similar to a postprandial state (i.e. high insulin), resulted in a decrease in
the fractional rate constant of progesterone decay compared to control groups as well as a
post-absorptive (i.e. high glucagon) treatment group (Smith et al., 2006).
Several authors have shown that a decrease in liver blood flow, by feeding half of
maintenance requirements, increases peripheral progesterone concentrations (Parr et al.,
1993; Sangsritavong et al., 2002). This relationship between hepatic catabolism of
progesterone and insulin concentrations may reveal a physiological control mechanism,
which allows an increase in liver blood flow while minimizing deleterious affects on
circulating progesterone concentrations. Our objectives were to determine the effect
insulin has on decreasing progesterone catabolic enzymes, thereby increasing peripheral
concentrations of progesterone, which could be utilized to decrease the high rates of
embryonic mortality observed in livestock.

2

REVIEW OF LITERATURE
Progesterone and Maintenance of Pregnancy
Adequate concentrations of progesterone are needed to maintain a successful
pregnancy. Csapo et al. (1956) proposed the “progesterone block hypothesis” while
studying pregnancy in the rabbit. This hypothesis states that progesterone maintains
pregnancy by directly blocking labor and that removal of progesterone will initiate
parturition (Csapo et al., 1956). Garfield et al. (1977) showed an increased insertion of
gap junctions between myometrial smooth muscle cells directly before and proceeding
through parturition, allowing for intercellular communication and synchronous
contraction of these cells. Progesterone prevented gap junction insertion between
myometrial smooth muscle cells in rats. Garfield et al. (1978) found that progesterone
supplementation in pregnant (days 16 to 17) ovariectomized rats was needed to prevent
the insertion of gap junction proteins between these smooth muscle cells. Gap junction
proteins are made up of a hexameric assembly of a group of proteins referred to as
connexins. The mRNA for connexin-43 in the rat, sheep and human was found to be
elevated near term and peaked during delivery due to a drop in concentrations of
progesterone (Orsino et al., 1996).
Several findings suggest that progesterone bound to its nuclear receptor (i.e.,
genomic actions) will modulate uterine contractility by acting to down-regulate
contraction-associated genes (Mesiano, 2007). While studying voltage-dependent
calcium channels in the rat myometrium, Tezuka et al. (1995) showed a 6.9-fold increase
in mRNA expression of voltage-dependent calcium channels directly before delivery (d
22), which could be blocked by treating with progesterone from day 19 to 22.
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Hirsbrunner et al. (2002) conducted an in vitro study on spontaneous myometrial
contractility, which showed that cows in estrus (0.5 ± 0.3 ng/ml of progesterone) had an
elevated contractility in circular smooth muscle cells of the myometrim compared to
cows in diestrus (4.8 ± 2.4 ng/ml of progesterone). These differences in myometrial
excitation-contraction are brought about by the genomic actions of progesterone, which
lead to a relaxed and quiescent uterus able to maintain a successful pregnancy until
progesterone withdrawal (Mesiano, 2007).
Progesterone Biosynthesis
Production of progesterone by the corpus luteum is essential in maintaining
pregnancy, and any deficiencies in luteal secretion that cause a reduction in progesterone
production, can be associated with an abrupt termination of pregnancy (Gorski et al.,
1958 and Miller et al., 1963). The first step in progesterone biosynthesis is the
endocytosis of cholesterol rich lipoproteins into luteal cells (Christenson et al., 2003).
Once inside the cell, cholesterol is transported from the outer mitochondrial membrane to
the inner mitochondrial membrane via steroidogenic acute regulatory protein (Stocco et
al., 2000). Inside the mitochondria, cholesterol can be converted enzymatically into
pregnenolone by P450 side chain cleavage (CYP11A1). Pregnenolone will then be
converted into progesterone via 3β-hydroxysteroid dehydrogenase, which is located on
the smooth endoplasmic reticulum.
Stormshak et al. (1963) estimated that the sheep corpus luteum, having an average
turnover rate of two minutes, produces approximately 15 to 30 mg of progesterone a day.
In sheep, the ovarian venous blood contains an average concentration of 1.52, 1.82, and
1.10 µg/ml of progesterone during the early, mid and late luteal phase, while peripheral
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concentrations are significantly less. Similar studies in cattle by Gomes et al. (1963),
estimated ovarian vein concentrations of progesterone to be 6.2 µg/ml while the jugular
vein contained only 11.6 ng/ml. During mid luteal phase, the corpus luteum contained 85
to 570 µg of progesterone with considerable cow-to-cow variation. In a similar study in
cows, Erb et al. (1967) estimated mean progestin concentrations in the ovarian vein as 2.6
µg/ml while jugular venous plasma averaged 26.7 ng/ml. Bridges et al. (2000)
determined that 300 mg of progesterone per day would maintain pregnancies in
lutectomized beef cows. McDonald et al. (1952) determined that 100 mg of progesterone
administered intramuscularly daily was needed to maintain pregnancy in a significant
number of lutectomized cattle before gestational day 200. However, limited research has
been done on estimating luteal progesterone production per day in the cycling or pregnant
dairy cow. By using a two minute turnover rate of progesterone (calculated by
Stormshak et al., 1963) from the corpus luteum, as well as average luteal content of
progesterone (calculated by Erb et al., 1967) we could estimate that a cow produces 300
to 500 mg per day depending on reproductive state.
Metabolic Clearance of Progesterone
Uterine and embryonic exposure to progesterone has been estimated to be higher
than peripheral tissue due to a counter-current exchange system within the utero-ovarian
adnexa (Einer-Jensen and Hunter, 2000). Ovarian venous plasma concentrations of
progesterone may be two to three orders of magnitude greater than peripheral
concentrations, and part of this relationship can be accounted for by dilution with
peripheral blood; however, low peripheral concentrations of progesterone may also be
due in part to a high rate of progesterone catabolism. Miller and colleagues (1963)
5

reported a half-life of 33.8 minutes for progesterone in cows. Short and Rowell (1962)
estimated a half-life of 7.3 minutes at day 115 of gestation in the ewe and 8.1 minutes
just prior to lambing. The normal high rate of catabolism may explain why blood
draining the ovary has a very high concentration of progesterone, during the mid luteal
phase, compared to jugular plasma progesterone concentrations, blood which has already
circulated through the liver and gut regions, where the majority of catabolism takes place.
In sheep, Weems et al. (1989) reported progesterone concentrations in the cranial
uterine venous plasma to be 5 ng/ml 9 days postestrus compared with 2 ng/ml in the
jugular plasma. This difference in concentration could be normalized after resection of
both oviductal veins, causing a drop in uternine venous concentrations of progesterone
down to 3 ng/ml (Weems et al., 1989). Weems and colleagues hypothesized a transfer of
progesterone from the uterine drainage to uterine arteries due to a progesterone gradient,
leading to higher concentrations of progesterone in the uterus compared to peripheral
tissues. Ginther (1974) diagramed the vascular system of the reproductive tract, which
indicated a close proximity between the uterine-ovarian drainage and the uterine artery.
Therefore, a counter-current exchange of progesterone between the utero-ovarian vein
and the uterine artery could supply progesterone to the uterus, bypassing peripheral
circulation (Einer-Jenson, 2005). However, the contribution of a counter current
exchange system in the ovarian adnexa has been estimated to be 0.3 – 2% of total steroids
(Einer-Jenson and Hunter, 2000). This is in agreement with the subtle differences
Weems and colleagues reported in uterine venous and jugular concentrations of
progesterone.
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Bedford et al. (1972, 1974) reported metabolic clearance rates (volume of blood
cleared per unit time) of progesterone to be approximately 3.5 to 4.3 l/min in sheep.
Splanchnic clearance of progesterone could account for 30% of peripherally administered
progesterone tracer catabolism, and of the total clearance in these splanchnic organs, 70 –
90% of progesterone was cleared by the liver (Bedford et al., 1974). Bedford and
colleagues injected progesterone into the jugular vein, which is not the normal route of
drainage for endogenously secreted progesterone and may explain why the liver only
accounts for 30% of total progesterone clearance in their studies. Other researchers have
reported greater hepatic progesterone clearance by injecting or infusing progesterone into
the lower extremities thereby mimicking the normal anatomical entry of progesterone
into systemic circulation. Gurpide (1975) estimated a 70% hepatic extraction of
progesterone in pregnant ewes, and Parr et al. (1993) determined that 96% of the
progesterone entering into the liver and gut region was metabolized by these tissues.
Taking into account that the liver is the primary site of progesterone catabolism,
several researchers have correlated liver blood flow, through the hepatic portal vein, and
the metabolic clearance rate of progesterone. Parr et al. (1993) showed that a 40%
increase in liver blood flow in sheep would double the metabolic clearance rate of
progesterone. Studies in the dairy cow by Sangsritavong et al. (2002) determined a
positive regression between liver blood flow and metabolic clearance rate of
progesterone, the relationship was determined to be metabolic clearance rate = 1.38(liver
blood flow) + 0.10 (r² = 0.92). However, these experiments compared a half maintenance
versus twice maintenance diet, which are not only confounded with dry matter intake, but
energy and protein intake as well. A drop in metabolic clearance rate may be due to a
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decrease in amino acid availability for protein synthesis, thereby decreasing the
production of progesterone catabolic enzymes. These strong correlations between
progesterone clearance and liver blood flow strengthen the notion that the primary site of
progesterone catabolism is the liver, and that altering liver physiology may turn out to be
a rational approach to raising progesterone concentrations during early pregnancy when
progesterone is essential.
In addition to the experimental approaches mentioned above, in which energy
and dry matter intake were confounded, Smith et al. (2006) demonstrated that anestrous
ewes orally gavaged with acetate or propionate (0.146 Mcal) and challenged with 20 mg
of progesterone, had different rates of progesterone clearance. These gavages were
isocaloric and diets contained equal dry matter, but stimulated markedly different insulin
secretion patterns. These authors proposed that elevated plasma insulin concentrations
were related to the observed reduction in progesterone catabolism. Smith et al. (2006)
also defined an in vitro system for determining fractional rates of decay for progesterone
by cultured hepatocytes. These authors determined that higher concentrations of insulin
(1 and 10 nM) decreased progesterone decay in culture media.
Cytochrome P450 Superfamily
Cytochrome P450s (EC 1.14.14.1; unspecific monooxygenase) are present in
most tissues, but most highly expressed in hepatocytes (P450 enzymes account for 1 to
2% of hepatocytes by weight) and are typically embedded in the smooth endoplasmic
reticulum (Ruckpaul and Rein, 1984). They are easily isolated by differential
centrifugation, known as a microsomal preparation. Cytochrome P450s function as
monooxygenases and are involved in the metabolism of a number of important
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endogenous compounds including vitamin D3 activation, catabolism of cholesterol to bile
acids, and metabolism of all major classes of steroid hormones (Waxman et al., 1991).
Cytochrome P450s are also involved in catabolizing a number of different exogenous
compounds such as repaglinide, rifampicin (Bidstrup et al., 2003), nifedipine,
mephenytoin (Guengerich et al., 1986) and omeprazole (Li et al., 2005). Cytochrome
P450s are not self-sufficient and require NADPH and cytochrome b5 as cofactors, and
cytochrome P450 reductase as a coenzyme, to function as catalytic monooxygenases
(Yamazaki et al., 1999). Cytochrome P450 reductase serves as an electron carrier by
transferring electrons from NADPH to cytochrome P450s (Yamazaki et al., 1999).
Cytochrome b5 has been found to increase the catalytic efficiency of different cytochrome
P450s, however the mechanism behind this increased efficiency has eluded researchers
for years.
In humans, the most abundant cytochrome P450 belongs to the 3 family, A
subfamily and polypeptide number 4, also known as cytochrome P450 3A4 or CYP3A4.
The cytochrome P450 3A subfamily accounts for approximately 30 to 40% of total P450
protein in human livers and the 3 major isoforms that have been discovered are CYP3A4,
CYP3A5 and CYP3A7. Yuan et al. (2002) reported that CYP3A4 is the most important
catabolic enzyme in the CYP3A subfamily in humans and its activity is generally
measured using testosterone, midazolam, nifedipine or erythromycin as specific
substrates (predominatly catabolized by CYP3A4 in humans and the CYP3A subfamily
of enzymes in other mammalian species). Of particular interest is the hydroxylation of
testosterone at the 6β position, which is accomplished by CYP3A4, CYP3A5, CYP3A7,
CYP2C9 and CYP2C19; however CYP3A4 accounts for 90% of 6β-hydroxytestosterone
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formation (Yuan et al., 2002), allowing for a fairly selective measurement of CYP3A4
activity with very low reactivity with the other members of the cytochrome P450
superfamily. The predominant substrates used by the pharmaceutical industry to measure
CYP2C19 activity are mephenytoin, omeprazole and diazepam (Yuan et al., 2002).
Studies by Li et al. (2005) showed that CYP2C19 and CYP3A4 both catabolize
omeprazole and that specific inhibitors of CYP2C19 or CYP3A4 are needed to determine
the activities for either one of the isozymes individually.
Cytochrome P450s and Steroid Metabolism
Using 11 different cDNA-expressed human cytochrome P450 isozymes
transfected into human hepatoma Hep G2 cells, Waxman et al. (1991) determined the
predominant cytochrome P450s that catabolize androstenedione, estradiol, progesterone
and testosterone. Androstenedione was predominantly catabolized into 6βhydroxyandrostenedione along with 3 other unknown products by CYP3A4, CYP3A3,
CYP3A5, CYP4B1 and CYP2C8, in order of highest activity to lowest. Estradiol was
predominantly catabolized into 2-hydroxyestradiol by CYP3A4, CYP3A3 and CYP1A2
in order of highest activity to lowest. Progesterone was predominantly catabolized into
6β-hydroxyprogesterone and 16α-hydroxyprogesterone along with 2 other unknown
products by CYP3A4, CYP3A3, CYP4B1, CYP3A5 and CYP2C8, in order of highest
activity to lowest. Testosterone was predominantly catabolized into 6βhydroxytestosterone, 2β-hydroxytestosterone and 15β-hydroxytestosterone along with 3
other unknown products by CYP3A4, CYP3A3, CYP4B1, CYP3A5 and CYP2C8 in
order of highest activity to lowest (Waxman et al., 1991). This study using transfected
human cytochrome P450s helped provide information on the extent of CYP3A
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conservation amongst mammals. However Waxman and colleagues only transfected 11
different isozymes to determine steroid catabolism, leaving a considerable gap in the
involvement of the > 40 other P450 isozymes in steroid catabolism (Estabrook, 1998)
Murray (1992) conducted work on progesterone catabolism in sheep, and found
that the most abundant progesterone hydroxylation products in hepatic microsomes were
6β, 21, 2α and 16α. Using antibodies raised against different isozymes of rat cytochrome
P450s, Murray (1991; 1992) showed the principal isozymes involved in progesterone
catabolism in sheep belonged to the cytochrome P450 2C and 3A subfamilies and the
major metabolites were found to be 21-hydroxyprogesterone and 6βhydroxyprogesterone, respectively (Murray, 1991; 1992). These enzymes were also
shown to catabolize testosterone in a manner similar to that demonstrated by Waxman et
al. (1991) adding substantial evidence that cytochrome P450 isozymes are conserved not
only amongst monogastrics but in ruminant species as well.
Regulation of Cytochrome P450s by Insulin and Glucagon
Sidhu and Omiecinski (1999) found a decreased expression of CYP3A1 mRNA in
rat hepatocytes cultured with 1 µM insulin and then exposed to phenobarbitol, a known
CYP3A1 inducer in rats. They also found a lower induction of CYP3A1 protein, due to
phenobarbitol exposure, in cells challenged with 1 nM insulin or physiological
concentrations of insulin for a 24 hour period (Sidhu and Omiecinski, 1999). Several
researchers have observed in enhanced expression of cytochrome P450 2E1, 2B, 3A and
4A mRNA in chemically induced diabetic rats, and that insulin administration can lower
the expression of these cytochrome P450s to normal (Barnett et al., 1990). At least part
of this increased expression of cytochrome P450 2E1, an acetone-inducible isozyme, has
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been attributed to hyperketonemia. Woodcroft and Novak (1999) showed that pyridinemediated induction of CYP2E1 mRNA and protein could be substantially decreased
when cells were cultured in the presence of 1 µM insulin for 96 hours compared to
primary cell cultures in the absence of insulin; however, insulin did not alter xenobiotic
(pyridine)-mediated expression of CYP2B, CYP3A and CYP4A.
By measuring the activity of cytochrome P450s, Saad et al. (1994) found a dosedependent decrease in testosterone hydroxylation at the 6β position when rat hepatocytes
were cultured with increasing concentrations of insulin (1, 10 and 100 nM), a reaction
that is primarily catalyzed by the CYP3A subfamily with minimal contribution from
CYP2C13 (Ryan and Levin, 1990). Formation of 6β hydroxytestosterone decreased 40%
when cells were cultured with 10 nM insulin compared to 1 nM insulin (Saad et al.,
1994). Saad et al. (1994) exposed hepatocytes to 1 nM insulin along with 0.1, 1.0, 10.0
and 100.0 nM glucagon to elucidate any responses due to glucagon exposure.
Hepatocytes exhibited a dose-dependent decrease in 6β testosterone hydroxylation with
increasing concentrations of glucagon. Formation of 6β hydroxytestosterone was
decreased nearly 20% when cells were cultured in the presence of 1.0 nM glucagon
compared to 0.1 nM glucagon (Saad et al., 1994). By comparing the work done by Saad
et al. (1994) exposing rat hepatocytes to insulin caused a greater decrease in
hydroxylation of testosterone at the 6β position compared to a challenge with
physiological concentrations of glucagon in rat hepatocyte primary cultures.
Cyclic AMP and Percent Oxygen
Sidhu and Omiecinski (1995) showed that primary cultures of rat hepatocytes
treated with diterpene, forskolin or glucagon stimulated cAMP production, which was

12

stable for 4 hours, and returned to basal levels by 24 hours. In examining possible signal
transducing pathways, Sidhu and Omiecinski (1995) showed that hepatocytes cultured
with increasing concentrations of dibutyryl-cAMP, a cAMP analog which mimics the
signaling pathway transduced through an active glucagon receptor complex, caused a
dose-dependent decrease in CYP2B1, CYP2B2 and CYP3A1 mRNA expression. Sidhu
and Omiecinski (1995) found a greater response in CYP2B1 and CYP3A1 mRNA
downregulation when substituting 8-(4-chlorophenylthio)-cAMP for the dibutyryl-cAMP
analog, and these responses were found to be substantially different at lower
concentrations than what is typically reported.
Berry and Skett (1988) were interested in hormonal regulation of steroid
metabolism, via measuring metabolism of androst-4-ene-3, 17-dione, after altering cAMP
concentrations. They found an inhibition of steroid catabolism (due to enzymatic
activity) at 30 and 60 minutes post-treatment at low levels of cAMP exposure, whereas
treatment with higher concentrations of cAMP caused a significant stimulation in steroid
catabolism suggesting both an inhibitory and stimulatory role for cAMP in steroid
catabolism. Banhegyi et al. (1988) reported cAMP-dependent positive control of
gluconeogenesis and cAMP-dependent negative control of cytochrome P450s. They
proposed that this relationship could help preserve substrates and endogenous compounds
from being catabolized during a time of starvation or fasting, when production of these
compounds may be limited. However, in vivo studies have shown that most members of
the cytochrome P450 3A subfamily are not down regulated via cAMP and appear to be
induced by fasting (Banhegyi et al., 1988; Miller and Yang 1984).
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Gebhardt (1992) described heterogeneous expression and induction of metabolic
enzymes in the liver, hypothesizing that the heterogeneous expression of cytochrome
P450s in hepatocytes may be due to micro-environmental differences within the liver.
The functional unit of the liver is a mixture of hepatocytes with similar morphology and
high variation in hepatocellular function. This functional unit, described as the liver
lobule, liver acinus or sickle zone lobule, consists of periportal cells, intermediate cells
and perivenous (pericentral) cells (Katz, 1992). Periportal hepatocytes are rich in oxygen
that is supplied via arterial and hepatic portal blood, creating an oxygen gradient
extending from the periportal to perivenous hepatic tissue. Perivenous hepatocytes are
predominant in gluconeogenesis, β-oxidation and glycogenolysis; however, they play a
limited role in oxidative xenobiotic metabolism (Katz, 1992). Saad et al. (1994)
investigated mixed function monooxygenase activity in rat hepatocytes exposed to
different levels of oxygen. Cells were exposed to oxygen levels that are typically found
for periportal or perivenous hepatic tissue, 13% and 4%, respectively. By measuring
testosterone hydroxylation activities, Saad et al. (1994) found an increase in production
of 16α and 16β hydroxytestosterone after phenobarbital induction, primarly catalyzed by
CYP2B1, in hepatocytes cultured with 13% oxygen. They also found an increase in 6β
hydroxytestosterone production after phenobarbital induction, primarly catalyzed by the
CYP3A subfamily, during exposure of hepatocytes to higher oxygen tensions, similar to
periportal tissue.
This study demonstrated that oxygen exposure impacts phenobarbital induction of
cytochrome P450 activity, which appears to be predominantly in periportal hepatocytes.
Cytochrome P450 activity was similar between hepatocytes cultured under 13% and 4%
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oxygen (media lacking phenobarbital); however perivenous hepatocytes do not
demonstrate phenobarbital induction (Saad et al., 1994). This heterogeneity of mixed
function monooxygenases in the liver appears to be due to an oxygen gradient. However,
insulin and glucagon challenges in hepatocytes cultured under similar conditions to
periportal or perivenous cells retain the ability to downregulate monooxygenase activity
after phenobarbital exposure. Krones et al. (2000) found a homogenous distribution of
insulin receptor mRNA in the sickle zone lobule, but the insulin receptor protein was
localized to the intermediate and distal perivenous hepatocytes. In rat hepatocyte primary
cultures exposed to 16% oxygen (periportal) or 8% oxygen (perivenous), the insulin
receptor protein was induced 2-fold after the addition of supraphysiological glucose
concentrations. Although both culture types had an equal induction of insulin receptor
protein, hepatocytes cultured under perivenous conditions (8% oxygen) had twice the
abundance of insulin receptor protein compared to their periportal (16% oxygen)
counterparts (Krones et al., 2000).
Krones and colleagues (1998) also described the localization of the glucagon
receptor to periportal cells. Glucagon receptor mRNA was expressed in both periportal
and perivenous hepatocytes; however, the addition of glucose to culture media caused an
increase in glucagon receptor mRNA in periportal hepatocytes, but not perivenous
hepatocytes. Katz (1992) reported that glucagon acts mainly in periportal tissue and
insulin in perivenous tissue; however the study by Saad et al. (1994) indicates that the
induction or suppression of cytochrome P450s due to insulin and glucagon challenges can
occur in hepatocytes exposed to either of the principal oxygen tensions.
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Volatile Fatty Acids
Alterations in ruminant feedstuffs leading to a difference in volatile fatty acid
production and ruminal pH can affect microbial yield and amino acid absorption (Russell
and Dombrowski, 1980). Thorlacius and Lodge (1973) compared ruminal pH and
absorption coefficients (mol/d) in cattle fed a hay diet versus a concentrate diet. They
found that ruminal pH ranged from 5.41 to 6.55 compared to 5.78 to 6.53 in hay diets and
concentrate diets, respectively. The absorption rates for acetate, propionate and butyrate
were 3 times greater in cattle fed the concentrate diet. The ratios of absorption for
acetate, propionate and butyrate were 1:2:4 for both diets studied (Thorlacius and Lodge
(1973), indicating that neither diet favored absorption of one volatile fatty acid over
another. The principal factor that alters absorption rates for acetate, propionate and
butyrate is ruminal pH, which can explain the similar absorption rates in the work
conducted by Thorlacius and Lodge (1973) where ruminal pH remained in the same
range (5.41 to 6.55) between the two diets. The predicted effect of ruminal pH on
volatile fatty acid specific absorption rate (absorption rate per unit rumen surface area
and per unit concentration) calculated by Pitt et al. (1996) shows that below pH 5.8
absorption rate increased with volatile fatty acid molecular weight. At a pH of 5.5 the
predicted absorption rates were 0.17, 0.30 and 0.37 (mol/d) for acetate, propionate and
butyrate, respectively, and increasing the pH caused a reduction in the predicted
absorption rates for all three, which is most notable for butyrate (Pitt et al., 1996).
The net portal appearance, the total absorption from the lumen of the
garstointestinal tract minus metabolism by these tissues, for acetate and propionate in
lactating dairy cows were calculated to be 1880 and 790 mmol/h and this accounted for
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40% of the metabolizable energy intake (Reynolds et al., 1988). Hepatocytes lack the
capacity to oxidize acetate (Demigne et al., 1986), and the uptake of acetate by the liver
is considered to be for biosynthetic, rather than oxidative purposes (Armentano, 1992);
however, acetate production by the liver exceeds utilization, making the liver a net
producer of acetate. In contrast, propionate clearance by the liver is approximately 90%
leaving 10% to be utilized by extrasplanchnic tissues (Reynolds et al., 1988). In vitro
saturation of hepatocytes with propionate is reached at 5 mmol/l; leading researchers to
believe that in vivo periportal hepatocytes (exposed to < 2 mmol/l of propionate in portal
blood) are functioning well below maximal capacity for propionate metabolism
(Armentano, 1992). The capacity for propionate metabolism in hepatocytes can be
dramatically altered by energy balance, which is most observable in dairy cows
experiencing a negative energy balance and lowered propionate metabolism caused by
excessive fat buildup in the liver (Armentano et al., 1991).
Volatile fatty acids produced via fermentation in the rumen of the cow contribute
36 to 80% of the energy absorbed from the gut (Casse et al., 1994). While studying the
transition period in dairy cows, Reynolds et al. (2003) found that between days 9 and 11
postpartum, 100% of the net liver glucose production was synthesized from propionate,
lactate, alanine, and glycerol (69.2, 19.5, 7.5, and 4.2%, respectively). However,
metabolic state and age may play an important part in the substrate utilized for glucose
production. During sodium propionate infusion into the mesenteric vein of lactating
dairy cows, Casse et al. (1994) estimated contributions of L-lactate, alanine, and
propionate to hepatic glucose production as 3, 2, and 94%, respectively. A single oral
gavage of sodium acetate or sodium propionate in sheep caused an elevation in
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concentrations of acetate or propionate in the hepatic portal vein, which was sustained for
4 hours when compared to sheep not orally gavaged with either acetate or propionate
(Smith et al., 2006). In this study only acetate could be detected in the jugular plasma
supporting the notion that the liver can convert essentially all portal propionate to glucose
(Smith et al., 2006).
Gluconeogenesis and Insulin Secretion
In ruminants, which have a very small net portal appearance of glucose, hepatic
gluconeogenesis accounts for a large proportion, if not all, of the circulating glucose
(Armentano, 1992). Baird et al. (1980) reported that the three major compounds taken up
for anabolism of glucose were propionate, lactate and pyruvate. Propionate is completely
exogenous in origin, and is only available from gut absorption, while the glucose
precursors lactate and pyruvate can be endogenous or exogenous in origin depending on
reproductive and nutritional state (Baird et al., 1980). For example, there is a net uptake
of pyruvate from the gut in lactating cows, versus a net output in non-lactating cows. In
general, gut output of propionate, hepatic output of glucose and hepatic uptake of lactate
are all increased during lactation (Baird et al, 1980).
The two major enzymes involved in hepatic gluconeogenesis are pyruvate
carboxylase and phosphoenolpyruvate carboxykinase. Velez and Donkin (2005) reported
an increase in pyruvate carboxylase in lactating cows fed half maintenance for 5 days
compared to ab libitum fed cows, while phosphoenolpyruvate carboxykinase was
unaffected by feed restriction. In this experiment, insulin and glucagon concentrations
were similar between half maintenance and ab libitum fed lactating dairy cows. In
contrast, work conducted by Reynolds and Tyrrell (1991) showed an increase in insulin
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and glucagon with increasing ME intake. The increase in pyruvate carboxylase, although
not due to altered levels of insulin or glucagon, supports increased use of lactate and
alanine for glucose synthesis in feed deprived ruminants (Filsell et al., 1969). In
monogastrics, administration of exogenous glucagon increases phosphoenolpyruvate
carboxykinase mRNA (Christ et al., 1988), while glucagon administration to sheep
caused an increase in pyruvate carboxylase activity, a key enzyme in converting lactate to
glucose (Brockman and Manns, 1974). Williams et al. (2006) reported that administering
glucagon to lactating dairy cows did not alter pyruvate carboxylase or
phosphoenolpyruvate carboxykinase activity or protein abundance. Williams et al.
(2006) determined similar rates of gluconeogenesis by infusing radiolabled propionate
and lactate in lactating dairy cows given glucagon or vehicle.
Pancreatic secretions differ in ruminants compared to non-ruminants because
ruminant species lack a measurable, postprandial, absorptive and post-absorptive state
(Harmon, 1992), due in part to ruminal fermentation, which leads to a continuous
absorption of fermentation end products, and a semi-constant flow of digesta. In
ruminants, volatile fatty acids have a dramatic influence on insulin and glucagon
secretion. In sheep, infusions of propionate, butyrate, valerate and isovalerate increased
insulin secretion, while an equal molar concentration infusion of acetate/kg BW did not
affect insulin secretion (Horino et al., 1968). Bassett (1972) found an increase in insulin
and glucagon secretion after equal molar infusions of propionate, butyrate, and valerate.
Mineo et al. (1990) found a dose-dependent increase in insulin secretion in sheep infused
with increasing concentrations of acetate at supraphysiological levels (321 to 5,000
µmol/kg BW); however, physiological concentrations of acetate are considered to play a
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limited role in regulating insulin secretion in vivo. In ewes, an oral gavage of sodium
propionate elevated peripheral concentrations of insulin at 30 and 60 minutes as well as
an elevation in glucagon concentrations at 30, 60 and 120 minutes versus ewes orally
gavaged with an isoenergetic amount of sodium acetate (Smith et al., 2006). Another
factor that contributes substantially to insulin and glucagon secretion is organic matter or
the amount of crude protein in feed. In rats, a high-carbohydrate diet caused a 20%
increase in insulin secretion, but a high-protein diet resulted in a two-fold greater hepatic
extraction of insulin and glucagon (Demigne et al., 1985). The majority of studies
showing no response to insulin and glucagon secretion in ruminants fed high-protein diets
are due to a failure to measure hepatic extraction of these hormones, which leads to a
decrease in peripheral concentrations (Harmon, 1992).
Diabetes
In streptozotocin-induced diabetic male rats, Leonelli et al. (2007) observed a
decrease in plasma progesterone concentrations. Arredondo and Noble (2006) reported
that patients with diabetes mellitus had an increased incidence of pregnancy loss, which
could be normalized by adequate glycemic control. Other researchers have found
evidence of lowered progesterone concentrations in women with diabetes; however, these
observations have not been associated with production and/or catabolism of progesterone.
Ueshiba et al. (2002) found a higher 17-hydroxyprogesterone to progesterone ratio in
type 2 diabetic women compared to age matched non-diabetic controls and these results
were assumed to be due to an increased activity in 17-hydroxylase, but could be
explained by increased progesterone catabolism. Salonia et al. (2006) found a substantial
difference in progesterone concentrations during the luteal phase in type 1 diabetic
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patients (3.6 nM progesterone) compared to controls (43.6 nM progesterone). These
differences in peripheral concentrations of progesterone can be attributed to either a
decrease in production of progesterone and/or an increase in hepatic catabolism.
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Abstract
Several authors have suggested that low concentrations of progesterone contribute to
pregnancy loss, an effect that may result from abnormally high progesterone catabolism.
In humans, cytochrome P450 2C19 (CYP2C19) and 3A4 (CYP3A4) contribute
substantially to progesterone catabolism. Recently, it was demonstrated that increasing
concentrations of insulin caused a dose-dependent decrease in progesterone catabolism,
in mouse hepatocytes. The objectives of this study were to determine if a four hour
challenge with insulin, glucagon or combinations of both insulin and glucagon at
different dosages can lead to a reduction in the relative abundance of CYP2C39 or
CYP3A13 mRNA (homologous to human CYP2C19 and CYP3A4), as well as a decrease
in the enzymatic activities of CYP2C and CYP3A subfamilies in these cells. A dosedependent decrease (P < 0.05) in CYP2C and CYP3A activity was observed in
hepatocytes challenged with increasing concentrations of insulin, while a challenge with
glucagon did not affect cytochrome P450 activity. Cytochrome P450 2C activity was
decreased (P < 0.05) during exposure of cells to 1.0 nM insulin and 0.1 nM glucagon as
well as to 0.1 nM insulin and 1.0 nM glucagon. Cells cultured with 1.0 nM insulin and
0.1 nM glucagon showed a trend (P < 0.10) for a decrease in CYP3A activity. The
relative abundance of CYP2C39 and CYP3A13 mRNA showed no response to insulin,
glucagon or the combination of insulin and glucagon exposure. These data support a
model in which the insulin-induced decrease in progesterone catabolism is a result of
reductions in CYP2C and CYP3A activity. Moreover, these data support a model in
which the regulation of these progesterone catabolic enzymes is mediated posttranscriptionally.
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Introduction
Adequate concentrations of progesterone are required for maintenance of
pregnancy. Several authors have shown that removal of the progesterone source results
in abortion of the fetus, which could be prevented by daily progesterone injections (1, 2).
Both progesterone production and/or hepatic catabolism of progesterone impact
peripheral concentrations of progesterone as well as uterine and embryonic exposure to
progesterone. Therefore, a drop in progesterone concentrations, due to low production or
the normal high rate of catabolism, can result in high embryonic mortality. Miller et al.
(3) reported a short half-life of 33.8 minutes for progesterone, and Bedford et al. (4,5)
reported the metabolic clearance rate (volume of blood cleared per unit time) of
progesterone approximated 3.5 to 4.3 L/min.
Parr et al. (6) estimated that 90% of progesterone entering the gut and liver is
metabolized by these tissues. Enzymes responsible for progesterone catabolism are
located on the endoplasmic reticulum and belong to the cytochrome P450 superfamily (7,
8). These enzymes convert progesterone into its respective hydroxyprogesterone
metabolites in the presence of reduced nicotinamide adenine dinuleotide phosphate
(NADPH). The cytochrome P450 enzymes responsible for the majority of progesterone
catabolism belong to the cytochrome P450 2C (CYP2C) and 3A (CYP3A) subfamilies (7,
8).
Dean and Stock (9) suggested an internal control mechanism, during pregnancy
that decreases total hepatic cytochrome P450 activity and elevated concentrations of
progesterone. Decreasing the activity of the enzymes responsible for progesterone
catabolism could increase the concentration of progesterone without the need for
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progesterone replacement. Smith et al. (10) observed a dose-dependent decrease in the
fractional rate constant of progesterone decay in a murine hepatocyte cell line cultured in
the presence of insulin. Treatment of hepatocytes with physiological concentrations of
insulin and glucagon, similar to a postprandial state (i.e. high insulin), decreased the
fractional rate constant of progesterone decay compared to control groups as well as a
post-absorptive (i.e. high glucagon) treatment group (10). Several authors have shown
that a decrease in liver blood flow, by feeding at half of maintenance requirements,
increased peripheral progesterone concentrations (6, 11). This relationship between
hepatic catabolism of progesterone and insulin concentrations may reveal a physiological
control mechanism that allows an increase in liver blood flow while minimizing
deleterious affects on circulating progesterone concentrations. This would allow
provision of the essential nutrients required for normal fetal development during
pregnancy without compromising progesterone concentrations to sub-optimal levels.
A relationship between insulin and cytochrome P450 expression was proposed
when Barnett et al. (12) and Shimojo et al. (13) observed enhanced expression of CYP3A
during diabetes, which was reversed by insulin replacement. Drug induced increases in
CYP2E1 mRNA and protein expression were inhibited in hepatocytes cultured for 96
hours with physiological concentrations of insulin (14). In streptozotocin-induced
diabetic rats, Barnett et al. (12) showed an increase in CYP3A1 expression and activity,
which was reversed by daily insulin therapy. Utilizing a rat hepatocyte primary culture,
Sidhu and Omiecinski (15) showed an inhibition of phenobarbital-induced CYP3A1
mRNA expression after insulin exposure. As a corollary to this, lowered insulin
concentrations due to diabetes may cause excessive catabolism of progesterone because
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of an enhanced expression of cytochrome P450s responsible for the metabolism of
endogenous compounds. The objectives of the current study were to determine if the
activities of CYP2C and CYP3A in a murine hepatocyte cell line or the relative
abundance of CYP2C39 and CYP3A13 mRNA, after a 4 hour challenge with varying
concentrations of insulin, glucagon or combinations of both insulin and glucagon may be
responsible for the observed decrease in progesterone clearance.
Materials & Methods
Cell Culture for Enzyme Activity Measurements
A mouse hepatocyte cell line from American Type Culture Collection (Manassas,
VA; cell-line FL83B, catalogue number CRL-2390) was cultured in F-12K media
(American Type Culture Collection), 10% fetal bovine serum (Thermo Fisher Scientifics,
Waltham, MA), and 500 IU penicillin/ml and 500 µg streptomyocin/ml (Invitrogen,
Carlsbad, CA). Cells (1.5 x 106 cells/flask) were expanded into 175 cm2 flasks (VWR
International, West Chester, PA) and allowed to reach ~ 60% confluence designated, as 0
hours. At this time, media were aspirated and replaced with fresh media containing 0
(control), 0.1, 1 or 10 nM insulin (Sigma Chemical Co., St. Louis, MO), 0 (control), 0.01,
0.1 or 1 nM glucagon (Sigma Chemical Co.); or a combination of insulin and glucagon (0
and 0 (control), 1.0 and 1.0, 1.0 and 0.1 or 0.1 and 1.0 nM, respectively) along with 5
ng/ml of progesterone (Sigma Chemical Co.) and cultured for an additional four hours.
After the four hour incubation cells were harvested using trypsin (Invitrogen), subjected
to centrifugation at 300 x g, and resuspended in 100 mM potassium phosphate buffer
containing 1 mM EDTA (pH 7.4). Cells were treated in duplicate on the same day and
then replicated in three separate experiments (n = 6).
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Microsomal Preparation
After resuspension of cells in 100 mM potassium phosphate buffer containing 1
mM EDTA (pH 7.4), cells were homogenized using a glass small clearance Dounce
homogenizer. Homogenized cells were subjected to centrifugation at 6000 x g for 8 min.
The pellet was discarded and the supernatant was centrifuged at 100,000 x g for 45 min
(16). Microsomal pellets were resuspended in 250 µl of 100 mM potassium phosphate
buffer containing 1 mM EDTA. Microsomal recovery was determined using a
cytochrome c reductase (NADPH) assay kit (Sigma Chemical Co.). Cytochrome P450
reductase activity was assessed in homogenized cells (i.e. all sub-cellular parts) and then
subsequently in microsomal preparations from the same sample. The recovery efficiency
cytochrome P450 reductase in our microsomal preparations was determined as described
in the manufacturers protocol, and ranged from 70 to 90%.
Cytochrome P450 Activity Assays
Cytochrome P450 2C activity was measured as the omeprazole-dependent
oxidation of NADPH (17). A stock solution of omeprazole (lot 115K1873, Sigma
Chemical Co.) was prepared in dimethyl sulfoxide at a concentration of 250 mM, and
then diluted with 100 mM potassium phosphate buffer containing 1 mM EDTA (pH 7.4)
to reach a final concentration of 2.5 mM omeprazole in each reaction containing
substrate. All CYP2C reactions contained 1% dimethyl sulfoxide either with or without
omeprazole. A stock solution of NADPH (lot 104K7034, Sigma Chemical Co.) was
prepared in potassium phosphate buffer containing 1 mM EDTA (pH 7.4) at a
concentration of 667 µM, which was added to each enzymatic reaction to reach a final
concentration of 250 µM. Due to the reactivity of omeprazole with CYP2C and CYP3A,
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a 15 min preincubation with 250 µM ketoconazole (lot 121H0524, Sigma Chemical Co.)
was used to inhibit CYP3A (18) and sufficient inhibition was determined by measuring
CYP3A activity, following preincubation with ketoconazole, (Figure 1), described in
detail below. Utilizing a serially diluted sample of microsomes to validate the
cytochrome P450 2C activity assay, we observed a linear relationship between the rates
of omeprazole-dependent NADPH oxidation and the activity of cytochrome P450
reductase (NADPH oxidation = 277.1 (cytochrome P450 reductase) + 0.16; Figure 2A).
Cytochrome P450 3A activity was measured as the nifedipine-dependent
oxidation of NADPH (19, 20). A stock solution of nifedipine (lot 115K1285, Sigma
Chemical Co.) was prepared in acetone at a concentration of 20 mM, and then diluted
with 100 mM potassium phosphate buffer containing 1 mM EDTA (pH 7.4) to reach a
final concentration of 200 µM nifedipine in each enzymatic reaction containing substrate.
All reactions measuring CYP3A activity contained 1% acetone either with or without
nifedipine. A stock solution of NADPH (lot 104K7034, Sigma Chemical Co.) was
prepared in potassium phosphate buffer containing 1 mM EDTA (pH 7.4) at a
concentration of 667 µM, which was added to each reaction to reach a final concentration
of 250 µM. Utilizing a serially diluted sample of microsomes to validate the CYP3A
activity assay, we determined the linear relationship between the rates of nifedipinedependent NADPH oxidation and the activity of cytochrome P450 reductase (NADPH
oxidation = 181.4 (cytochrome P450 reductase) + 0.39; Figure 2B).
Enzymatic reactions contained 25 µl of microsomes, 75 µl of phosphate-buffered
NADPH, and 100 µl of substrate or potassium phosphate buffer loaded into UV star 96
well plates (PGC Scientifics, San Diego, CA). The oxidation of NADPH was determined
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Figure 1: Inhibition of cytochrome P450 3A activity using different concentrations of
ketoconazole. After a 15 minute preincubation with the inhibitor, microsomes were
assayed for cytochrome P450 3A activity.
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Figure 2: Validation of cytochrome P450 2C assay utilizing microsomal dilutions versus
oxidation of NADPH per minute (A). Validation of cytochrome P450 3A assay utilizing
microsomal dilutions versus oxidation of NADPH per minute (B).
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by measuring the decrease in light absorbed at 340 nm (37 ˚C) for 5 min using a Spectra
max Plus plate reader (Molecular Devices, Inc., Sunnyvale, CA). Cytochrome P450 2C
and 3A reactions remained linear for 10 minutes after the addition of NADPH.
Cell Culture for Determination of mRNA Expression Utilizing Real Time RT-PCR
The same mouse hepatocyte cell line utilized for the determination of cytochrome
P450 enzyme activities was treated as described above. After treatment with insulin,
glucagon or a combination of insulin and glucagon for 4 hours, media were aspirated and
RNA was extracted with TRIzol LS reagent (Invitrogen) and precipitated with 2-propanol
following the manufacturers protocol. Concentrations of RNA in each sample were
determined using a Nanodrop ND-1000 spectrophotometer. One µg of RNA was
electrophoresed through a 1.5% agarose gel to determine sample purity and for
visualization of 28S and 18S rRNA bands.
Real Time RT-PCR was performed as previously described (21). Briefly,
samples were diluted to 1 µg RNA/µl and reverse transcribed using moloney murine
leukemia virus reverse transcriptase (Promega, Madison, WI) following the
manufacturers protocol. Acidic ribosomal protein (ARP) was used as a reference gene,
and CYP2C39 and CYP3A13 were chosen due to their homology with the major
progesterone catabolic enzymes in the human, CYP2C19 and CYP3A4. Primers for
ARP, CYP2C39 and CYP3A13 (Integrated DNA Technologies, Inc., Coralville, IA) are
shown in Table 1. Amplification was optimal at an annealing temperature of 59 ˚C and
efficiencies for ARP, CYP2C39, and CYP3A13 were 1.96, 1.95 and 2.16, respectively
(Table 1). The relative abundances of mRNA for CYP2C39 and CYP3A13 were
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Table 1: Primer sets used for Real Time RT-PCR.

Gene

Accession no.

Forward primer

Reverse Primer

Efficiency

CYP2C39

NM_010003

cct atg gcc ctg tgt tca ct

cag aaa act cct ccc cat ga

1.96

CYP3A13

NM_007819

aag tac tgg cca gag cct ga

aat gca gtt cct tgg tcc ac

2.16

ARP

NM_007475

caa ccc agc tct gga gaa ac

gtg agg tcc tcc ttg gtg aa

1.95
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corrected for PCR efficiency, standardized using ARP and expressed relative to a pooled
sample, as described by Costine et al. (21).
Statistical Analysis
The effects of insulin or glucagon on enzymatic activity and mRNA expression of
CYP2C and CYP3A were analyzed using linear regression, employing the general linear
model of SAS. The effects of a combination of both insulin and glucagon were tested
with ANOVA utilizing the GLM procedure of SAS (SAS software version 9.1).
Results
Cytochrome P450 2C and 3A activities in mouse hepatocytes incubated for four
hours with varying concentrations of insulin are illustrated in Figures 3A and B,
respectively. There was a dose-dependent decrease (P = 0.029) in CYP2C activity in
response to insulin treatment (CYP2C Activity = -23.4[Insulin] + 543.7; r2 = 0.20).
Similarly, there was a dose-dependent decrease (P = 0.002) in CYP3A activity in
response to insulin treatment (CYP3A Activity = -11.6[Insulin] + 145.6; r2 = 0.27). We
found no response to insulin treatment in the relative mRNA abundance for CYP2C39 (P
= 0.165) and CYP3A13 (P = 0.844).
Cytochrome P450 2C and 3A activities in mouse hepatocytes incubated for four
hours with varying concentrations of glucagon are illustrated in Figures 4A and B,
respectively. There was no observed effect of glucagon on CYP2C (P = 0.143) or
CYP3A (P = 0.664) activity. Increasing concentrations of glucagon had no effect on the
relative abundance of CYP2C39 (P = 0.932) and CYP3A13 (P = 0.609) mRNA.
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Figure 3: Cytochrome P450 2C activity in mouse hepatocytes after a four hour treatment
with varying concentrations of insulin (A). Open bar is at 0 hours, before treatment with
insulin and progesterone. Cytochrome P450 3A activity in mouse hepatocytes after a
four hour treatment with varying concentrations of insulin (B). Open bar is at 0 hours,
before treatment with insulin and progesterone. Cytochrome P450 2C and 3A activity is
expressed per minute per mUnit of cytochrome P450 reductase activity.
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Figure 4: Cytochrome P450 2C activity in mouse hepatocytes after a four hour treatment
with varying concentrations of glucagon (A). Open bar is at 0 hours, before treatment
with glucagon and progesterone. Cytochrome P450 3A activity in mouse hepatocytes
after a four hour treatment with varying concentrations of glucagon (B). Open bar is a 0
hours, before treatment with glucagon and progesterone.

35

Cytochrome P450 2C and 3A activities in mouse hepatocytes incubated for four
hours in the presence of insulin and glucagon at different concentrations are illustrated in
Figures 5A and B, respectively. Cytochrome P450 2C activity was unaffected by
treatment with 1.0 nM insulin and 1.0 nM glucagon. Cytochrome P450 2C activity in
hepatocytes cultured with 1.0 nM insulin and 0.1 nM glucagon decreased (P = 0.003)
compared to controls. Hepatocytes cultured with 0.1 nM insulin and 1.0 nM glucagon
also showed a decrease (P = 0.029) in CYP2C activity. Cytochrome P450 3A activity in
hepatocytes cultured with 1.0 nM insulin and 0.1 nM glucagon tended to be lower (P =
0.098) than the control groups (no insulin or glucagon), and was decreased (P = 0.006)
compared to CYP3A activity in hepatocytes cultured with 1.0 nM insulin and 1.0 nM
glucagon. The relative abundances of CYP2C39 (P = 0.440) and CYP3A13 (P = 0.440)
mRNA in hepatocytes did not change due to treatment with insulin and glucagon.
Discussion
Mouse hepatocytes treated with insulin showed a dose-dependent decrease in the
activities of both CYP2C and CYP3A. These observations strengthen the notion that
these enzymes are responsible for a majority of progesterone catabolism, as hepatocytes
cultured under the same conditions and concentrations of insulin also exhibited a dosedependent decrease in progesterone catabolism (10). Regulating progesterone catabolism
by decreasing CYP2C and CYP3A activities in response to insulin treatment could
increase circulating concentrations of progesterone, thus leading to increased
reproductive efficiency. Endogenous compounds such as progesterone as well as
xenobiotics (i.e. pyridine, phenobarbital and ciprofibrate) have been known to induce the
expression of the cytochrome P450s responsible for their catabolism. Extensive studies

36

CYP3A Activity, pmol/min*mU

CYP2C Activity, pmol/min*mU

500

a

A

a

400

300

b
200

b
100

B
250
200

a
a, b

a, b

150

b

100
50
0

Insulin, nM 0.0
Glucagon, nM 0.0

0.0
0.0

1.0
1.0

1.0
0.1

0.1
1.0

Figure 5: Cytochrome P450 2C activity in mouse hepatocytes after a four hour treatment
with varying concentrations of insulin and glucagon (A, hatched bars). Open bar is at 0
hours, before treatment with insulin, glucagon and progesterone. Cytochrome P450 3A
activity in mouse hepatocytes after a four hour treatment with varying concentrations of
insulin and glucagon (B, hatched bars). Open bar is a 0 hours, before treatment with
insulin, glucagon and progesterone. Letters a and b indicate a difference between
treatment groups (P < 0.05).

37

exist on the enzymatic processes carried out by cytochrome P450s as well as the
mechanisms behind their induction; however, a limited number of studies have been
focused on decreasing these enzymes without the use of toxic inhibitors, reviewed by
Hewitt et al. (22).
It is well established that chemically induced or spontaneous diabetes enhances
expression of cytochrome P450 2E1, 2B, 3A and 4A, and that insulin administration to
streptozotocin-induced diabetic rats lowered the expression of these cytochrome P450s to
basal levels (12). The hyperketonemia associated with diabetes is responsible, at least in
part, for the increased expression of cytochrome P450 2E1, an acetone-inducible
isozyme. Woodcroft and Novak (14) showed that pyridine-mediated induction of
CYP2E1 mRNA and protein abundance could be substantially decreased when cells were
cultured in the presence of 1 µM insulin for 96 hours; however, insulin exposure did not
affect xenobiotic-mediated expression of CYP2B, CYP3A and CYP4A. Sidhu and
Omiecinski (15), focused on CYP3A1 expression rather than the CYP3A subfamily,
found a decreased expression of CYP3A1 in rat hepatocytes cultured with 1 µM insulin
and then exposed to phenobarbitol, a known CYP3A1 inducer in rats. They also found a
lower induction of CYP3A1, due to phenobarbitol exposure, in cells exposed to
physiological (i.e., 1 nM) concentrations of insulin (15).
Saad et al. (23) found a dose-dependent decrease in testosterone hydroxylation at
the 6β position when rat hepatocytes were cultured with increasing concentrations of
insulin (1, 10 and 100 nM), a reaction that is catalyzed primarily by the CYP3A
subfamily with minimal contribution from CYP2C13 (24). This is similar to our
findings, which show a dose-dependent decrease in CYP3A and CYP2C activities using

38

0.1, 1 and 10 nM insulin concentrations. Formation of 6β hydroxytestosterone decreased
40% when cells were cultured in 10 nM insulin compared to 1 nM insulin (23), whereas
we found a 20% decrease in CYP2C activity and a 60% decrease in CYP3A activity
when cells were cultured in 10 nM compared to 1 nM insulin.
In the current study, CYP2C and CYP3A activities were unchanged in a murine
hepatocyte cell line treated with increasing concentrations of glucagon. Saad et al. (23)
exposed hepatocytes to 1 nM insulin along with 0.1, 1.0, 10.0 and 100.0 nM glucagon to
elucidate any responses due to glucagon exposure. In contrast to our results hepatocytes
exhibited a dose dependent decrease in 6β testosterone hydroxylation with increasing
concentrations of glucagon. This may have resulted because glucagon concentrations at
10.0 and 100.0 nM are well beyond physiological concentrations. However, formation of
6β hydroxytestosterone was decreased nearly 20% when cells were cultured in the
presence of 1.0 nM glucagon compared to 0.1 nM glucagon (23). In contrast we found
no differences in CYP2C or CYP3A activities after a glucagon challenge. Saad et al.
(23) found that exposing rat hepatocytes to insulin caused a greater decrease in
hydroxylation of testosterone at the 6β position compared to a challenge with
physiological concentrations of glucagon.
Cytochrome P450 3A activity tended to be lower in cells treated with 1.0 nM
insulin and 0.1 nM glucagon compared to control cells. Due to the regulatory actions of
insulin and glucagon on a number of cytochrome P450s, Sidhu and Omiecinski (15)
suggested that insulin and glucagon should be added to hepatocyte cultures at
physiological concentrations when studying drug metabolism in vitro. Saad et al. (23)
showed a 20 % decrease in 6β hydroxytestosterone production in cells cultured with 1
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nM insulin and 1 nM glucagon compared to 1 nM insulin and 0.1 nM glucagon. In
examining possible signal transducing pathways, Sidhu and Omiecinski (25) showed that
hepatocytes cultured with increasing concentrations of dibutyryl-cAMP, a cAMP analog
which mimics the signaling pathway transduced through an active glucagon receptor
complex, caused a dose-dependent decrease in CYP2B1, CYP2B2 and CYP3A1 mRNA
expression. They found a greater response in CYP2B1 and CYP3A1 mRNA
downregulation when substituting 8-(4-chlorophenylthio)-cAMP for the dibutyryl-cAMP
analog, and these responses were substantially different at lower concentrations than
typically reported in the literature.
The findings in previous studies, which report downregulation of cytochrome
P450 mRNA after exposure to insulin, glucagon or cAMP analogs were from
experiments in which cell cultures were exposed to treatments for 24, 48 or 96 hours
(which is at least 20 hours longer than our treatments). Liver exposure to elevated
concentrations of insulin and glucagon may be as short as one or two hours per day,
which may be enough time to regulate activity while having little to no effect on mRNA.
In the current experiment, mouse hepatocytes were challenged with physiological
concentrations of insulin, glucagon or insulin and glucagon for four hours, and relative
abundances of CYP2C39 and CYP3A13 mRNA did not differ. Berry and Skett (26)
were interested in hormonal regulation of steroid metabolism, via measuring metabolism
of androst-4-ene-3, 17-dione, after altering cAMP concentrations. They found an
inhibition of steroid catabolism (due to decreased enzymatic activity) at 30 and 60
minutes post-treatment at low dosages of cAMP, whereas treatment with higher
concentrations of cAMP stimulated steroid catabolism, so they suggested both inhibitory
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and stimulatory roles for cAMP in steroid catabolism. Banhegyi et al. (27) reported an
inverse relationship between cAMP-dependent positive control of gluconeogenesis and
the cAMP-dependent negative control of cytochrome P450s. They proposed that this
relationship could help preserve substrates from being catabolized during a time of
starvation or fasting. However, in vivo studies have shown that most members of the
cytochrome P450 3A subfamily are not down regulated via cAMP and appear to be
induced by fasting (28, 29).
Regulation of CYP2C and CYP3A via insulin describes a logical system, which
could facilitate lowered progesterone catabolism. In streptozotocin-induced diabetic
male rats, Leonelli et al. (30) observed a decrease in plasma progesterone concentrations.
Arredondo and Noble (31) reported that patients with diabetes mellitus had an increased
incidence of pregnancy loss that could be normalized by adequate glycemic control.
Other researchers have found evidence of lower progesterone concentrations in women
with diabetes; however, these observations have not been associated with rates of
production and/or catabolism of progesterone. Ueshiba et al. (32) found a higher ratio of
17-hydroxyprogesterone to progesterone in type 2 diabetic women compared to age
matched non-diabetic controls and these results were assumed to be due to an increased
activity in 17-hydroxylase, but could be explained by increased progesterone catabolism.
Salonia et al. (33) found a substantial difference in progesterone concentrations during
the luteal phase in type 1 diabetic patients (3.6 nM progesterone) compared to controls
(43.6 nM progesterone). These differences in peripheral concentrations of progesterone
can be attributed either to lower progesterone production and/or an increase in its
catabolism.
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In conclusion, a logical mechanism to decrease progesterone catabolism, via
cytochrome P450 down-regulation, in animals with excessive metabolism, could be used
to increase concentrations of progesterone due to deficiencies in luteal secretion. Our
results show a decrease in activity of the progesterone catabolic enzymes after treatment
with physiological concentrations of insulin. Diet may play an essential role in regulating
peripheral concentrations of progesterone via insulin and glucagon secretion by
regulating its hepatic clearance from the body. Methods that increase peripheral
concentrations of progesterone will impact uterine and embryonic exposure to
progesterone thereby improving retention of pregnancy.
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Abstract
Pregnancy rates in dairy cows have steadily declined the last 50 years and several authors
have suggested that this is related to low peripheral concentrations of progesterone. The
primary organ involved in the catabolism of progesterone is the liver, and cytochrome
P450 2C and 3A subfamilies account for a large proportion of this catabolism.
Previously, ewes orally gavaged with propionate, a gluconeogenic substrate, had elevated
insulin secretion and reduced progesterone catabolism. A dose-dependent decrease in
progesterone catabolism was demonstrated by hepatocytes challenged with increasing
concentrations of insulin, as well as a dose-dependent decrease in the activity of the two
major cytochrome P450s involved in progesterone catabolism. The objectives of the
current experiment were to determine if supplementing feed with either sodium acetate or
sodium propionate altered peripheral concentrations of insulin, hepatic activity of
cytochrome P450 2C and 3A, and/or progesterone clearance. Sixteen ovariectomized
ewes were fed 3 kg/d for 10 d a diet consisting of 50% corn silage, 38% triticale haylage,
12% soybean meal, and 200 mL of 3.5 M sodium acetate (energy control n = 8) or 2.0 M
sodium propionate (gluconeogenic substrate; n = 8). Insulin concentrations were
determined immediately before feeding and at 15, 30, 60, 90, 120, 180, 240, and 300 min
after feeding. Progesterone clearance from peripheral circulation was measured by
giving a 5 mg injection of progesterone into the left jugular vein and collecting blood via
the right jugular vein at 2, 4, 6, 8, 10, 15, 20 and 30 min afterwards. Liver biopsies were
taken one hour after feeding for determination of cytochrome P450 2C and 3A activities.
Insulin concentrations in ewes supplemented with sodium propionate were elevated at 15,
30 and 60 minutes after feeding compared to the sodium acetate group. Cytochrome
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P450 2C and 3A activity were decreased 1 h after feeding in the sodium propionate
treated ewes relative to sodium acetate. Clearance of progesterone from the peripheral
circulation, one hour after feeding, was similar between treatments, as was the average
fractional rate constant of progesterone clearance (k). Elucidating a mechanism to
decrease progesterone catabolism, thereby increasing embryonic and uterine exposure to
progesterone, seems a logical approach to ameliorate high rates of embryonic loss
without compromising DMI.
Key words: progesterone catabolism, sheep, insulin, cytochrome P450
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Introduction
Pregnancy rates in dairy cows have declined 30% in the last 50 years, and
approximately 80% of the total loss of pregnancy occurs during the embryonic stage,
before day 42 (Inskeep and Dailey, 2005). Several authors have suggested that low
concentrations of progesterone may lead to an abrupt termination of pregnancy
(McDonald et al., 1952; Robinson et al., 1989; Stevenson and Mee 1991). Starbuck et al.
(2004) reported increased pregnancy retention in dairy cows that were classified as
having high concentrations of progesterone compared to low at day 30. Plasma
progesterone concentrations may be reduced due to a decrease in production and/or an
increase in hepatic catabolism. The two major enzymes involved in progesterone
catabolism belong to the cytochrome P450 2C and 3A subfamilies and the major
metabolites are 21-hydroxyprogesterone and 6β-hydroxyprogesterone, respectively
(Murray, 1991 and 1992).
Smith et al. (2006) found that ewes orally gavaged with sodium propionate, a
gluconeogenic substrate, had increased serum concentrations of insulin and decreased
progesterone clearance compared to ewes orally gavaged with an isocaloric amount of
sodium acetate (non-gluconeogenic). To elucidate the mechanisms involved in the
observed decrease in progesterone catabolism, the authors utilized a murine hepatocyte
cell line. Hepatocytes cultured in the presence of insulin had a dose-dependent reduction
in the fractional rate constant for progesterone decay compared to controls (Smith et al.,
2006). Therefore, the objectives of the current experiment were to determine if altering
the type of energy provided, rather than the amount of energy, by supplementing feed
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with sodium acetate or sodium propionate, altered insulin concentrations, hepatic activity
of cytochrome P450 2C and 3A, and/or progesterone clearance after feeding.
Materials and Methods
Animals and Feeding
Sixteen ovariectomized ewes were blocked by weight and randomly assigned to
experimental treatments. Ewes were housed individually in 3 m x 3 m pens for the
experimental period of ten days. Animal care and use was according to a protocol
approved by the West Virginia University Animal Care and Use Committee (ACUC no.
04-0604). Ewes had ad libitum access to water and were fed 3 kg/d of a standard ewe
ration containing 50% corn silage, 38% triticale haylage and 12% soybean meal (on an as
fed basis). The DM content of the mixed ration was 38.4% with 17.6% crude protein and
62.1% TDN (DM basis). Equal portions of the ration (1 kg as fed basis) were offered
three times daily at 0600, 1400, and 2200 h. The ewes consumed all of the feed within
30 to 45 min. Ewes were allowed 2 d (d 1 and d 2) to adapt to the individual housing and
the new feeding schedule before either propionate or acetate supplementation was
introduced. Sodium acetate (lot 085K0003, Sigma Chemical Co., St. Louis, MO) or
sodium propionate (lot 035K0039, Sigma Chemical Co.) was then introduced in a stepwise manner with 1/3 treatment provided on d 3, followed by 2/3 of the full treatment on
d 4 and finally full treatment for the subsequent days (d 5 through d 10). The treatments
consisted of either 0.7 mol sodium acetate or 0.4 mol sodium propionate dissolved in 200
ml of water. These amounts of acetate and propionate were calculated to be isocaloric
(0.146 Mcal). The sodium acetate or sodium propionate solutions were mixed into the
above ration directly before each feeding.
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Sample Collection and Hormone Analysis
On d 9, a jugular catheter was inserted prior to the morning feeding. At 0600 h
ewes were fed their respective diets. One h after feeding, at 0700 h, ewes were given 5
mg of progesterone i.v. in the left jugular vein. Blood samples were collected via the
right jugular vein at 2, 4, 6, 8, 10, 15, 20 and 30 min after progesterone administration
into pre-chilled EDTA containing tubes. Progesterone concentrations from the jugular
plasma samples were determined using RIA (Sheffel et al., 1982) with a sensitivity of
100 pg/ml and intra- and interassay CV of 4.6 and 7.6%, respectively. Fractional rate
constants of progesterone clearance (k) were determined for each individual ewe utilizing
the equation [P]t = [P]o e-kt, which describes a first order exponential decay curve.
On d 10 blood was collected via jugular venipuncture directly before feeding
(0600 h) and at 15, 30, 60, 90, 120, 180, 240 and 300 min after feeding into pre-chilled
EDTA containing tubes. Jugular plasma insulin was measured using an insulin RIA kit
(lot TKIN 870, Diagnostic Products Corporation, Los Angeles, CA) with a sensitivity of
0.05 nM and intra- and interassay CVs of 1.4 and 7.8%, respectively. The assay was
validated to measure sheep insulin in our laboratory. Briefly, plasma dilutions from two
different ewes were assayed for insulin and exhibited parallelism with the standard curve.
Liver biopsies were taken on d 10 following the 60 min blood sampling as
described by Navarre and Pugh (2002). The wool was removed from the animals’ right
side and the skin was scrubbed twice with betadine. After determining the location of the
ninth intercostal space, 2% lidocaine hydrochloride (lot 6050804, Columbus Serum,
Columbus, OH) was administered as a local anesthetic. The skin was punctured using a
scalpel and a 14 gauge x 16 cm biopsy needle (J-118A, Jorgensen Laboratories Inc.,
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Loveland, CO) was used to collect the liver samples. Liver samples were submerged in
100 mM potassium phosphate buffer containing 1 mM EDTA (pH 7.4), placed on ice,
and immediately prepared for determination of cytochrome P450 2C and 3A activities.
Microsomal Preparation
After suspending liver tissues in 100 mM potassium phosphate buffer containing
1 mM EDTA (pH 7.4), samples were homogenized using a glass Dounce homogenizer.
Homogenized samples were subjected to centrifugation at 10,000 x g for 10 min. The
pellet was discarded and the supernatant was centrifuged at 100,000 x g for 60 min
(modified from Nelson et al., 2001). The microsomal pellets were resuspended in 500 µl
of 100 mM potassium phosphate buffer containing 1 mM EDTA (pH 7.4). Microsomal
recovery was determined using a cytochrome c reductase (reduced nicotinamide adenine
dinuleotide phosphate; NADPH) assay kit (product number CY0100, Sigma Chemical
Co.). Cytochrome P450 reductase activity was assessed in homogenized tissue (all subcellular parts) and subsequently in microsomal preparations from the same sample. The
recovery of cytochrome P450 reductase in our microsomal preparations was determined
as described in the manufacturers protocol and ranged from 70 to 90%.
Enzymatic Activity
Cytochrome P450 2C activity was measured as the omeprazole-dependent
oxidation of NADPH (modified from Li et al., 2005). A stock solution of omeprazole
(lot 115K1873, Sigma Chemical Co.) was prepared in dimethyl sulfoxide at a
concentration of 250 mM, and then diluted with 100 mM potassium phosphate buffer
containing 1 mM EDTA (pH 7.4) to reach a final concentration of 2.5 mM omeprazole in
each enzymatic reaction containing substrate. All cytochrome P450 2C reactions
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contained 1% dimethyl sulfoxide either with or without omeprazole. A stock solution of
NADPH (lot 104K7034, Sigma Chemical Co.) was prepared in potassium phosphate
buffer containing 1 mM EDTA (pH 7.4) at a concentration of 667 µM, which was added
to each enzymatic reaction to reach a final concentration of 250 µM. Due to the reactivity
of omeprazole with cytochrome P450 2C and 3A, a 15 min preincubation with 250 µM
ketoconazole (lot 121H0524, Sigma Chemical Co.) was used to inhibit cytochrome P450
3A (Bidstrup et al., 2003) and sufficient inhibition was determined by measuring
cytochrome P450 3A activity with nifedipine, described in detail below. Utilizing a
serially diluted sample of liver microsomes to validate the cytochrome P450 2C activity
assay, a linear relationship was observed between the rates of omeprazole-dependent
oxidation of NADPH versus the activity of cytochrome P450 reductase (NADPH
oxidation = 44.77(cytochrome P450 reductase) – 0.04; Figure 6).
Cytochrome P450 3A activity was measured as the nifedipine-dependent
oxidation of NADPH (modified from Guengerich et al., 1986 and Bork et al., 1989). A
stock solution of nifedipine (lot 115K1285, Sigma Chemical Co.) was prepared in
acetone at a concentration of 20 mM, and then diluted with 100 mM potassium phosphate
buffer containing 1 mM EDTA (pH 7.4) to reach a final concentration of 200 µM
nifedipine in each enzymatic reaction containing substrate. All enzymatic reactions for
cytochrome P450 3A contained 1% acetone either with or without nifedipine. A stock
solution of NADPH (lot 104K7034, Sigma Chemical Co.) was prepared in potassium
phosphate buffer containing 1 mM EDTA (pH 7.4) at a concentration of 667 µM, which
was added to each enzymatic reaction to reach a final concentration of 250 µM. Utilizing
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Figure 6: Validation of cytochrome P450 2C activity. A liver microsome sample was
diluted and the rate of omeprazole-dependent oxidation of NADPH as well as the activity
of cytochrome P450 reductase were measured to determine linearity of the assay with
respect to enzyme amount.
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a serially diluted sample of liver microsomes to validate the cytochrome P450 3A activity
assay, a linear relationship was observed between the rates of nifedipine-dependent
oxidation of NADPH versus the activity of cytochrome P450 reductase (NADPH
oxidation = 6.86(cytochrome P450 reductase) – 0.01; Figure 7).
Enzymatic reactions contained 25 µl of microsomes, 75 µl of phosphate-buffered
NADPH, and 100 µl of substrate or potassium phosphate buffer loaded into UV star 96
well plates (PGC Scientifics, Fredrick, MD). The oxidation of NADPH was determined
by measuring the amount of light absorbed at 340 nm (37 ˚C) for 5 min using a Spectra
max Plus plate reader (Molecular Devices, Inc., Sunnyvale, CA). Cytochrome P450 2C
and 3A reactions remained linear for 10 minutes after the addition of NADPH.
Statistical Analysis
The effects of treatments on cytochrome P450 2C, cytochrome P450 3A and
progesterone clearance (k) were tested with ANOVA utilizing the GLM procedure of
SAS (SAS software version 9.1). The effect of treatment on insulin concentrations were
tested using a repeated measures ANOVA utilizing the mixed procedure of SAS with an
autoregressive covariance structure, and means were separated using PDIFF option of the
mixed procedure. Least square means and standard error of means are reported.
Statistical significance was declared at P ≤ 0.05.
Results
Insulin concentrations before feeding (0600 h) were the same for ewes in the
acetate and propionate groups (Figure 8). At 15 and 30 min after feeding, ewes
supplemented with propionate had elevated insulin concentrations compared to the
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Figure 7: Validation of cytochrome P450 3A activity. A liver microsome sample was
diluted and the rate of nifedipine-dependent oxidation of NADPH as well as the activity
of cytochrome P450 reductase was measured to determine linearity of the assay with
respect to enzyme amount.
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Figure 8: Plasma concentrations of insulin in ewes supplemented with 0.7 mol sodium
acetate or 0.4 mol sodium propionate at different time points relative to feeding at 0 min.
* indicates a difference between treatment groups at that time point (P < 0.05).
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acetate-supplemented group (P < 0.05; Figure 8). At 60 min after feeding, insulin
concentrations in propionate-supplemented ewes began to decline, but were still elevated
compared to the acetate-supplemented group (P < 0.05; Figure 8). During the
postprandial state, 90 min to 300 min, insulin concentrations did not differ among or
between groups and were the same as time 0 (or 8 h after the previous feeding).
Cytochrome P450 2C activity in liver tissue from the propionate-supplemented
ewes was reduced (P < 0.05) to nearly one-half of the activity in liver tissue from acetatesupplemented ewes (Figure 9). Cytochrome P450 3A activity was reduced in liver of the
propionate-supplemented ewes (P = 0.05) to nearly one-half of that in acetatesupplemented ewes (Figure 9).
Progesterone concentrations prior to the injection of 5 mg of progesterone were
less than 0.3 ng/ml. In the sodium propionate and sodium acetate supplemented ewes
72% of the injected progesterone, 10 min after progesterone administration, had been
either catabolized by the liver or taken up by extra-hepatic tissues (Figure 10). Due to the
high variability of progesterone clearance from the peripheral circulation during the first
6 min of blood sampling these time points were not used in determining the fractional
rate constants of progesterone clearance. Fractional rate constants of progesterone
clearance (k) were determined for each individual ewe utilizing progesterone
concentrations from 8, 10, 15, 20 and 30 min relative to progesterone injection. Although
the progesterone clearance was numerically lower in the propionate-supplemented group
this difference was not significant (Figure 11). A power test, using the means and
variances generated from these data, estimated that 40 observations for each treatment
would be needed to detect a significant effect of treatment.
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Figure 9: Enzymatic activity of cytochrome P450 2C and cytochrome P450 3A in liver
biopsies taken 1 hour after feeding in ewes supplemented with sodium acetate or sodium
propionate. Enzymatic activities are scaled to cytochrome P450 reductase. * indicates a
difference in treatment (P ≤ 0.05).
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Figure 10: Progesterone concentrations in ewes injected with 5 mg of progesterone 1
hour after feeding rations supplemented with 0.7 mol sodium acetate or 0.4 mol sodium
propionate. Plasma samples for determination of progesterone concentrations were
collected at 2, 4, 6, 8, 10, 15, 20 and 30 min.
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Figure 11: Mean fractional rate constants of progesterone decay in ewes supplemented
with 0.7 mol sodium acetate or 0.4 mol sodium propionate. Fractional rate constants
were determined by graphing progesterone concentrations versus time (8, 10, 15, 20 and
30 min) with the equation [P]t = [P]o e-kt.
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Discussion
Insulin concentrations peaked 30 min after feeding in both the acetate
supplemented and the propionate supplemented groups. The increase in insulin
concentration was three times greater in propionate as compared to acetate-supplemented
ewes, which would be expected because of the gluconeogenic properties of propionate.
Volatile fatty acids produced via fermentation in the rumen of the cow contribute 36 to
80% of the energy absorbed from the gut (Casse et al., 1994). While studying the
transition period in dairy cows, Reynolds et al. (2003) found that between days 9 and 11
postpartum, 100% of net liver glucose production was synthesized from propionate,
lactate, alanine, and glycerol (69.2, 19.5, 7.5, and 4.2%, respectively). Casse et al. (1994)
estimated contributions of L-lactate, alanine, and propionate to hepatic glucose
production, during sodium propionate infusion into the mesenteric vein of lactating dairy
cows, as 3, 2, and 94%, respectively. These results are in agreement with the present
observations of increased jugular concentrations of insulin in ewes supplemented with
sodium propionate.
However, metabolic state and age may play an important part in the substrate
utilized for glucose production, thereby leading to elevated insulin secretion. In vitro
saturation of hepatocytes with propionate is reached at 5 mmol/l. Several authors have
suggested that in vivo periportal hepatocytes, exposed to < 2 mmol/l of propionate in
portal blood, are functioning well below maximal capacity for propionate metabolism
(Armentano, 1992). The capacity for propionate metabolism in hepatocytes can be
dramatically altered by energy balance, which is most observable in dairy cows
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experiencing a negative energy balance and lowered propionate metabolism caused by
excessive fat buildup in the liver (Armentano et al., 1991).
A single oral gavage of sodium acetate or sodium propionate in sheep elevated
concentrations of acetate or propionate in the hepatic portal vein, which was sustained for
4 hours when compared to sheep not orally gavaged with either acetate or propionate
(Smith et al., 2006). An oral gavage of sodium propionate resulted in greater insulin
concentrations in peripheral circulation at 30 and 60 minutes as well as higher glucagon
concentrations at 30, 60 and 120 minutes versus animals orally gavaged with sodium
acetate (Smith et al., 2006). The peak insulin concentration and the pattern of the insulin
response curve to either propionate or acetate observed by Smith et al. (2006) was very
similar to the response observed in this study, despite the difference in the method of
propionate or acetate delivery between the two studies.
Murray (1992) found that the most abundant hydroxylation products of
progesterone in hepatic microsomes of sheep were 6β, 21, 2α and 16α
hydroxyprogesterone metabolites. A member of the cytochrome P450 2C subfamily was
involved in metabolizing progesterone into its 21-hydroxyprogesterone metabolite, and a
member of the cytochrome P450 3A subfamily was involved in metabolizing
progesterone into its 6β-hydroxyprogesterone metabolite, as determined by measuring
different metabolites after immunoinhibition with specific anti-P450s (Murray 1991,
1992). Dean and Stock (1975) observed a decrease in overall hepatic microsomal
cytochrome P450s during pregnancy, which led them to hypothesize a biological control
mechanism to elevate serum progesterone concentrations by decreasing catabolism. In
the current experiment, activities for cytochrome P450 2C and 3A decreased 1 hour after
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feeding in ewes supplemented with sodium propionate compared to sodium acetate. This
time is congruent with the time over which propionate supplementation continued to
result in increased secretion of insulin, which would be expected to decrease hepatic
progesterone catabolism. Therefore, we believe the decreased progesterone clearance
observed by Smith et al. (2006) was mediated by decreased cytochrome P450 2C and 3A
activities, although clearance of progesterone from peripheral circulation in the present
study did not differ.
Bedford et al. (1972, 1974) reported metabolic clearance rates (volume of blood
cleared of progesterone per unit time) for progesterone to be approximately 3.5 to 4.3
L/min in sheep. Splanchnic clearance rate of progesterone could account for 30% of total
progesterone metabolism, and 70 – 90% of the total clearance of progesterone in these
splanchnic organs of was cleared by the liver (Bedford et al., 1974). In these studies
metabolic clearance rates were determined by infusing progesterone into the peripheral
circulation via the jugular vein, which is different from the in vivo source of
progesterone, primarily produced in the ovary or the gravid uterus both of which are part
of the portal drained viscera. Therefore, others have reported greater hepatic
progesterone clearance, by infusing progesterone into the lower extremities because this
progesterone is first taken to the liver for metabolism before entering whole body
circulation. Gurpide (1975) estimated a 70% hepatic extraction of progesterone in
pregnant ewes, and Parr et al. (1993) determined that 96% of the progesterone entering
into the liver and gut region was metabolized by these tissues.
Taking into account that the liver is the primary site of progesterone catabolism,
several researchers have correlated liver blood flow through the hepatic portal vein and
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metabolic clearance rate of progesterone. Parr et al. (1993) showed that a 40% increase
in liver blood flow in sheep almost doubled the metabolic clearance rate of progesterone.
Studies in the dairy cow by Sangsritavong et al. (2002) determined a positive correlation
between liver blood flow and metabolic clearance rate of progesterone. The relationship
was determined to be metabolic clearance rate = 1.38(liver blood flow) + 0.10 (r² = 0.92).
However, these studies compared high versus low maintenance diets, which differed in
energy, protein and DMI. This strong correlation between progesterone concentration
and liver blood flow only strengthens the notion that the primary site of progesterone
catabolism is the liver, and that altering liver physiology may be a plausible approach to
raising progesterone concentrations during early stages in pregnancy when progesterone
is essential. In the current work, consumption of dietary DM was equal for the two
treatment groups, and dietary treatments were both isocaloric and isonitrogenous. These
diets resulted in a 45% decrease in the activity of progesterone catabolic enzymes,
without confounding changes in DMI or the amount of crude protein available.
After an oral gavage of sodium acetate or sodium propionate, serum progesterone
concentrations began to diverge at 30 min in anestrous ewe lambs given an i.m. injection
of 20 mg of progesterone and were greater in the sodium propionate ewes at 3 and 4
hours after treatment (Smith et al., 2006). Lower progesterone clearance was then
associated with elevated insulin concentrations rather than elevated glucagon
concentrations. Utilizing a murine hepatocyte cell line, a dose-dependent decrease in the
fractional rate constant of progesterone clearance was observed with increasing
concentrations of insulin (Smith et al., 2006). These results are in agreement with work
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by Selvaraju et al. (2002), who demonstrated that a s.c. injection with long acting bovine
insulin elevated serum progesterone concentrations in repeat breeder cows.
In the current work, cytochrome P450 activity was reduced 45% with propionate
supplementation; however we observed no difference in progesterone fractional clearance
rates. Administering progesterone into the jugular vein may have limited hepatic
catabolism and/or increased extra-hepatic uptake of progesterone from the plasma. In
conclusion, ewes supplemented with sodium propionate (a gluconeogenic substrate) had
elevated concentrations of insulin at 15, 30, and 60 minutes after feeding as well as lower
cytochrome P450 2C activity and a trend for lower cytochrome P450 3A activity
compared to ewes supplemented with sodium acetate (energy control).
Implications
Insulin appears to play an essential role in regulating progesterone catabolic
enzyme activity in the liver. Identifying feedstuffs that can increase insulin without
concomitantly increasing liver blood flow might help mitigate excessive progesterone
catabolism without the need to reduce intake below maintenance requirements.
Progesterone production and/or hepatic catabolism of progesterone both impact
peripheral concentrations of progesterone as well as uterine and embryonic exposure to
progesterone. Therefore elucidating a mechanism that decreases the activity of
progesterone catabolic enzymes could provide for increased progesterone concentrations
and possibly decreased embryonic loss.
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GENERAL DISCUSSION
Exposing a mouse hepatocyte cell line to varying concentrations of insulin,
glucagon or a combination of both insulin and glucagon for four hours had an impact on
the activity of cytochrome P450 2C and 3A subfamilies, however, these insulin and
glucagon challenges did not alter the relative abundance of cytochrome P450 2C39 and
3A13 mRNA. Insulin challenges of 0.0, 0.1, 1.0 and 10.0 caused a dose dependent
decrease in cytochrome P450 2C and 3A activities, while glucagon exposure had no
affect on cytochrome P450 activity. Cytochrome P450 2C activity was unaffected by
treatment with 1.0 nM insulin and 1.0 nM glucagon compared to controls (no insulin or
glucagon). Cytochrome P450 2C activity in hepatocytes cultured with 1.0 nM insulin
and 0.1 nM glucagon or 0.1 nM insulin and 1.0 nM glucagon decreased compared to
controls. Cytochrome P450 3A activity in hepatocytes cultured with 1.0 nM insulin and
0.1 nM glucagon tended to be lower than the control groups, and was decreased
compared to CYP3A activity in hepatocytes cultured with 1.0 nM insulin and 1.0 nM
glucagon. These observations strengthen the notion that these enzymes are responsible
for a majority of progesterone catabolism, as hepatocytes cultured under the same
conditions and concentrations of insulin also exhibited a dose-dependent decrease in
progesterone catabolism (Smith et al., 2006). The differential response in progesterone
catabolic enzyme activity, after insulin and glucagon exposure, leads us to believe that
this mechanism may be a plausible approach to decrease progesterone catabolism in vivo.
To test this hypothesis, we set out to determine if supplementing feed with either
sodium acetate (energy control) or sodium propionate (gluconeogenic substrate) altered
insulin concentrations, hepatic activity of cytochrome P450 2C and 3A, and/or
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progesterone clearance. At 15 and 30 min after feeding ewes supplemented with
propionate had elevated insulin concentrations compared to the acetate-supplemented
group. At 60 min after feeding insulin concentrations in propionate-supplemented ewes
began to decline but were still elevated compared to the acetate-supplemented group. At
one hour after feeding, when insulin concentrations were still elevated, the activity of
cytochrome P450 2C and 3A were decreased in propionate-supplemented ewes compared
to acetate-supplemented ewes; however, no difference in the clearance of progesterone
from peripheral circulation was detected between the treatment groups. Insulin clearly
regulates progesterone catabolic enzymes, and identifying feedstuffs that decrease their
activity in vivo, without altering blood flow to the liver, could increase peripheral
concentrations of progesterone.
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